Rifoligotyping assay: an alternative method for rapid detection of rifampicin resistance in Mycobacterium tuberculosis isolates from Morocco

References

• World Health Organization (WHO). Anti-Tuberculosis drug resistance in the world. Fourth Global Report. 2008. Geneve: World Health Organization. WHO/HTM/TB/2008.394.
   Google Scholar
• Keshavjee S, Farmer PE. Tuberculosis, drug resistance, and the history of modern medecine. N England J Med. 2012;367(10):931–936.
   PubMed Web of Science ®Google Scholar
• Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843.
   PubMed Web of Science ®Google Scholar
• Alcaide F, Coll P. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance. Enferm Infecc Microbiol Clin. 2011;29(1):34–40.
   PubMedGoogle Scholar
• Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol. 2006;8(2):97–111.
   PubMed Web of Science ®Google Scholar
• Sorlozano A, Soria I, Roman J, Huertas P, Soto MJ, Piedrola G, Gutierrez J. Comparative evaluation of three culture methods for the isolation of mycobacteria from clinical samples. J Microbiol Biotechnol. 2009;19(10):1259–1264.
   PubMed Web of Science ®Google Scholar
• Tessema B, Beer J, Emmric F, Sack U, Rodloff AC. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. BMC Infect Dis. 2012;12:37.
   Google Scholar
• Abe C. Standardization of laboratory tests for tuberculosis and their proficiency testing. Kekkaku. 2003;78(8):541–551.
   PubMedGoogle Scholar
• Simons SO, van Soolingen D. Drug susceptibility testing for optimizing tuberculosis treatment. Curr Pharm Des. 2011;17(27):2863–2874.
   PubMed Web of Science ®Google Scholar
• Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–544.
   PubMed Web of Science ®Google Scholar
• Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev. 1995;8:496–514.
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: update. Tuberc Lung Dis. 1998;79:3–29.
   PubMedGoogle Scholar
• Lemus D, Martin A, Montoro E, Portaels F, Palomino JC. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2004;54(1):130–133.
   PubMed Web of Science ®Google Scholar
• Miller LP, Crawford JT, Shinnick TM. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1994;8:805–811.
   Google Scholar
• Nisha A, Govindarajan S, Muthuraj M, Manupriya S, Usharani B, Kamatchyammal S, Saroja V. Molecular characterization of rpoB gene encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from south India. African J Biotechnol. 2012;11(13):3160–3168.
   Google Scholar
• Cole ST, Telenti A. Drug resistance in Mycobacterium tuberculosis. Eur Respir J. 1995;Suppl20:701s–713s.
   Google Scholar
• Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad. 1997;94:9869–9874.
   PubMed Web of Science ®Google Scholar
• Kourout M, Chaoui I, Sabouni R, Lahlou O, El Mzibri M, Jordaan A, Victor TC, Akrim M, El Aouad R. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Morocco. Int J Tuberc Lung Dis. 2009;13(11):1440–1442.
   PubMed Web of Science ®Google Scholar
• Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis. 1998;4:195–209.
   PubMed Web of Science ®Google Scholar
• Jureen P, Werngren J, Hoffner SE. Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2004;84:311–316.
   PubMed Web of Science ®Google Scholar
• Zhang SL, Shen JG, Xu PH, Li DX, Sun ZQ, Li L, Yang ZR, Sun Q. A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array. J Appl Microbiol. 2007;103:1262–1271.
   PubMed Web of Science ®Google Scholar
• Victor TC, Jordaan AM, van Rie A, van der Spuy GD, Richardson M, van Helden PD, Warren R. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuberc Lung Dis. 1999;79:343–348.
   PubMedGoogle Scholar
• Van Rie A, Warren R, Mshanga I, Jordaan AM, van derSpuy GD, Richardson M, Simpson J, Gie RP, Enarson DA, Beyers N, van Helden PD, Victor TC. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol. 2001;39:636–641.
   PubMed Web of Science ®Google Scholar
• Victor TC, van Helden PD, Warren R. Prediction of drug resistance in Mycobacterium tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life. 2002;53(4–5):231–237.
   PubMed Web of Science ®Google Scholar
• Weyer K, Mirzayev F, Migliori G, Van Gemert W, D’Ambrosio L, Zignol M, Floyd K, Centis R, Cirillo D, Tortoli E, Gilpin C, Iragena J, Falzon D, Raviglione M. Rapid molecular TB diagnosis: evidence, policy-making and global implementation of Xpert(R) MTB/RIF. Eur Respir J. 2013;42:252–271.
   PubMed Web of Science ®Google Scholar
• Piatek AS, Tyagi S, Pol AC, Telenti A, Miller LP, Kramer FR, Alland D. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol. 1998;16(4):359–363.
   PubMed Web of Science ®Google Scholar
• El-Hajj HH, Marras SA, Tyagi S, Kramer FR, Alland D. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol. 2001;39(11):4131–4137.
   PubMed Web of Science ®Google Scholar
• Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O’Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. Rapid molecular detection of tuberculosis and rifampin resistance. N England J Med. 2010;363(11):1005–1015.
   PubMed Web of Science ®Google Scholar
• Morcillo N, Zumarraga M, Alito A, Dolmann A, Schouls L, Cataldi A, Kremer K, van Soolingen D. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2002;6:959–965.
   PubMed Web of Science ®Google Scholar
• Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, Meissner G, Mitchison DA, Sula L. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ. 1963;29:565–578.
   PubMed Web of Science ®Google Scholar
• Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41:21–43.
   PubMed Web of Science ®Google Scholar
• Senna SG, Gomes HM, Ribeiro MO, Kristki AL, Rossetti ML, Suffys PN. In house reverse line hybridization assay for rapid detection of susceptibility to rifampicin in isolates of Mycobacterium tuberculosis. J Microbiol Methods. 2006;67:385–389.
   PubMed Web of Science ®Google Scholar
• Dorman SE. New diagnostic tests for tuberculosis: bench, bedside, and beyond. Clin Infect Dis. 2010;50(3):173–177.
   Web of Science ®Google Scholar
• Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkarni SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J Microbiol Methods. 2004;57:323–335.
   PubMed Web of Science ®Google Scholar
• Ajbani K, Shetty A, Mehta A, Rodrigues C. Rapid diagnosis of extensively Drug-resistant tuberculosis by use of reverse line blot hybridization assay. J Clin Microbiol. 2011;49(7):2546–2551.
   PubMed Web of Science ®Google Scholar
• Heep M, Brandstatter B, Rieger U, Lehn N, Richter E, Rüsch-Gerdes S, Niemann S. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol. 2001;39:107–110.
   PubMed Web of Science ®Google Scholar
• Kapur V, Li LL, Iordanescu S, Hamrick MR, Wanger A, Kreiswirth BN, Musser JM. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol. 1994;32(4):1095–1098.
   PubMed Web of Science ®Google Scholar
• Patra SK, Jain A, Sherwal BL, Khanna A. Rapid Detection of Mutation in RRDR of rpoB gene for Rifampicin Resistance in MDR-Pulmonary Tuberculosis by DNA Sequencing. Indian J Clin Biochem. 2010;25(3):315–318.
   Google Scholar
• Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6(9):1067–1082.
   PubMed Web of Science ®Google Scholar
• Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008;32(5):1165–1174.
   PubMed Web of Science ®Google Scholar
• Xu HB, Jiang RH, Sha W, Li L, Xiao HP. PCR-single–strand conformational polymorphism method for rapid detection of rifampin-resistant Mycobacterium tuberculosis : systematic review and meta-analysis. J Clin Microbiol. 2010;48(10):3635–3640.
   PubMed Web of Science ®Google Scholar
• Kremer K, van Zetten, van Embden J, Shouls L, van Soolingen D. ‘RIFO ASSAY’: a PCR reverse line blot hybridization method to detect rifampin resistance. Bilthoven: National Institute of Public Health and Environment; 2003.
   Google Scholar
• Suresh N, Singh UB, Arora J, Pande JN, Seth P, Samantaray JC. Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by in-house, reverse line blot assay. Diagn Microbiol Infect Dis. 2006;56:133–140.
   PubMed Web of Science ®Google Scholar
• Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–914.
   PubMed Web of Science ®Google Scholar
• Neuta IH, Varela A, Martin A, von Groll A, Jureen P, López B, Imperiale B, Sķenders G, Ritacco V, Hoffner S, Morcillo N, Palomino JC, Del Portillo P. Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2010;48(12):4386–4391.
   PubMed Web of Science ®Google Scholar
• Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol. 2006;44:3659–3664.
   PubMed Web of Science ®Google Scholar